LPL PvuII genotype | LPL mass (ng/mL) Tertile range | Non-MetSyn N (%)a | MetSyn N (%)a | OR (95% CI)b | OR (95% CI)c | |
---|---|---|---|---|---|---|
P1P1/P1P2 | Tertile 1d | ≦34.20 | 21 (11.7%) | 48 (25.4%) | 1.00e | 1.00e |
Tertile 2 | 34.21–49.50 | 30 (16.7%) | 39 (20.6%) | 0.73 (0.43–1.25) | 0.85 (0.36–1.98) | |
Tertile 3 | ≧49.51 | 44 (24.4%) | 24 (12.7%) | 0.35 (0.20–0.62) | 1.04 (0.49–2.21) | |
P2P2 | Tertile 1 | ≦34.20 | 35 (19.4%) | 47 (24.9%) | 0.57 (0.34–0.96) | 0.70 (0.34–1.47) |
Tertile 2 | 34.21–49.50 | 29 (16.1%) | 20 (10.6%) | 0.46 (0.25–0.83) | 0.67 (0.28–1.63) | |
Tertile 3 | ≧49.51 | 21 (11.7%) | 11 (5.8%) | 0.39 (0.19–0.78) | 1.15 (0.42–3.13) | |
P for trend | 0.002 | 0.588 | ||||
Total subject | Tertile 1 | ≦34.20 | 56 (31.1%) | 95 (50.3%) | 1.00e | 1.00e |
Tertile 2 | 34.21–49.50 | 59 (32.8%) | 59 (31.2%) | 0.82 (0.55–1.21) | 0.89 (0.48–1.67) | |
Tertile 3 | ≧49.51 | 65 (36.1%) | 35 (18.5%) | 0.49 (0.32–0.76) | 1.26 (0.69–2.32) | |
P for trend | 0.002 | 0.489 |